In conclusion, upon inflammation and IL-6 secretion from the microenvironment, the STAT3 pathway becomes activated and promotes CRC stemness and malignancy through the transcriptional (promoter binding) and posttranslational (K116 deacetylation) upregulation of FOSL1/FRA1. Here, STAT3 is linked to colorectal carcinoma.